All Sauce from Weekly Sauce:

WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer’s disease. The findings from a phase 3 clinical trial have yet to be peer-reviewed in any medical journal. But according to a company news release, “lecanemab treatment…  read on >  read on >

It’s very frustrating to get a COVID-19 vaccine and then wind up catching the virus anyway. But these breakthrough infections actually do you a world of good, providing a powerful boost to your existing vaccine-induced immune protection, a new study reports. People infected after getting a basic two-dose COVID vaccination experienced an immune response equal…  read on >  read on >

Combining weightlifting with aerobic exercise can significantly lower your odds dying early, especially from heart disease, new research shows. Depending how much weightlifting they did, older adults reduced their risk of premature death by between 9% and 22%, the study found. Moderate or vigorous aerobic exercise lowered the risk by 24% to 34%. The lowest…  read on >  read on >

Getting up on the wrong side of bed can happen to the best of folks. Not everyone greets every morning with a sunny disposition and big smile. But when a bad mood overlaps with work, many people feel pressured to just snap out of it and “get happy.” New research suggests that forcing that sort…  read on >  read on >

WEDNESDAY, Sept. 28, 2022 (HealthDay News) – Millions of seniors who had to pay high increases in Medicare premiums this year will get a break in 2023 when they see a rare drop in monthly premiums for Medicare Part B. The rate decrease is 3%, which will reduce what most people pay for a variety…  read on >  read on >

Use of the over-the-counter sleep aid melatonin is increasing among young people, and calls to poison control centers and visits to the emergency room are also on the rise. This is mostly because young children and teens are accidentally ingesting more of the supplement than is safe, according to the U.S. Centers for Disease Control…  read on >  read on >

Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistant to remdesivir, according to researchers at NYU Grossman School of Medicine and…  read on >  read on >